<?xml version="1.0" encoding="UTF-8"?>
<ref id="B51-ijerph-17-00440">
 <label>51.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Reau</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Kwo</surname>
    <given-names>P.Y.</given-names>
   </name>
   <name>
    <surname>Rhee</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Brown</surname>
    <given-names>R.S.</given-names>
    <suffix>Jr.</suffix>
   </name>
   <name>
    <surname>Agarwal</surname>
    <given-names>K.</given-names>
   </name>
  </person-group>
  <article-title>Glecaprevir/Pibrentasvir Treatment in Liver or Kidney Transplant Patients with Hepatitis C Virus Infection</article-title>
  <source>Hepatology</source>
  <year>2018</year>
  <volume>68</volume>
  <fpage>1298</fpage>
  <lpage>1307</lpage>
  <pub-id pub-id-type="doi">10.1002/hep.30046</pub-id>
  <?supplied-pmid 29672891?>
  <pub-id pub-id-type="pmid">29672891</pub-id>
 </element-citation>
</ref>
